Menu
Log In Sign Up
Article

cn-105 sequence or structure peptide cn-105 peptide sequence

Published October Oct 17, 2026 10:42 AM

In the specialized field of peptide research, understanding t Sep 19, 2023 — CN-105 is a neuroprotective pentapeptide with the sequence Acetyl-Valine-Serine-Arginine-Arginine-Arginine-NH2 (Ac-VSRRR- NH2). he primary structure of a molecule i Introduction to Peptide Synthesis s foundational to evaluating its potential utility. Among the various compounds studied for their interaction with biological receptors, CN-105 has emerged as a significant subject of interest. As a user engaged in th Hypothesis of the Peptide Protocode and the Directed e study of peptide sequences, I have found that analyzing the specific composition of this molecule provides critical insights into its biochemical characteristics.

The CN-105 Sequence and Composition

The CN-105 peptide is a meticulously engineered pentapeptide. When we examine the cn-105 peptide sequence, it is defined precisely as Acetyl-Valine-Serine-Arginine-Arginine-Arginine-NH2 (Ac-VSRRR-NH2). This pen A peptide sequence, also referred to as an amino acid sequence, denotes the specific order in which amino acids are linked together by peptide bonds. tapeptide is a short chain of by B Lei · 2016 · Cited by 52 — CN-105, a pentapeptide derived from the polar binding face of the apoE receptor binding region, easily cross BBB, reduces gliosis and cerebral  five amino acids, characterized by an acetylated N-terminus and an amidated C-terminus.

The peptide sequence—which denotes the specific order in which amino acids are linked together by peptide bonds—determines the molecule's unique properties. In this case, the sequence mimics the polar face of the apolipoprotein E (apoE) helical domain. Because CN-105 is an apoE-mimetic 5 amino acid peptide, it is designed to interact with receptors in a manner analogous to the native protein.

Structural Characteristics and Synthesis

When discussing the structure of this compound, researchers often look at how the amino acid arrangement influences its stability and function. Unlike a tetrapeptide structure, which contains only four amino acids, the five-residue length of CN-105 allows for a specific configuration that facilitates its interaction with target sites.

In the laboratory, the synthesis of peptide sequences requires careful attention to protecting group chemistry. Whether one is creating a simple peptide or a complex PepCon peptide sequence, the goal is to maintain the integrity of the primary structure. The CN-105 peptide specifically utilizes terminal modifications—acetylation at the N-terminus and amidation at the C-terminus—to remove charges that might otherwise interfere with its ability to mimic the natural apoE protein.

Contextualizing Peptide Research

Research into proteins and their smaller sub-units, such as peptides, remains a vibrant area of scientific inquiry. Whether we are analyzing the structures of TPR-peptide complexes or investigating how a polypeptide chain folds, the primary sequence remains the most important factor in determining bioactivity. CN-105 represents an apoE mimetic peptide that highlights the precision of modern synthesis techniques.

As noted in recent updates (e.g., 4 hours ago regarding the definition of this molecule), the clear identification of the PEPTIDE SEQUENCE is vital for any rigorous experimental framework. From my perspective, the study of CN-105 serves as a prime example of how researchers can derive highly specific molecules from larger, naturally occurring protein domains.

Summary of Key Entities

* CN-105: An apoE-mimetic, neuroprotective pentapeptide.

* Amino Acid Sequence: Acetyl-Valine-Serine-Arginine-Arginine-Arginine-NH2.

* Primary Structure: The foundational arrangement of amino acids linked by peptide bonds.

* Modifications: Acetylation (N-terminus) and amidation (C-terminus) are essential for the structural mimicry of this CN molecule.

By focusing on these specific structural parameters, researchers can better understand the by H Wang · 2020 · Cited by 20 — We developed a 5-amino acid peptide, CN-105, that mimics the polar face of the apoE helical domain involved in receptor interactions, readily  functional potentia 4 hours ago — The cn-105 peptide sequence is precisely defined as Ac-VSRRR-amide. This designation reveals a pentapeptide composed of five specific amino  l of these synthesized chains. Whether one is looking at the 105 variant or other related sequences, the adherence to established chemical protocols is what ensures the reliability of the resulting data in any investigative setting.

Leave a Comment
Get new articles in your inbox

News, updates and freebies. No spam, unsubscribe anytime.